Read More

Celyad Oncology Q4 2022 Business Update And 2023 Outlook; As Of Dec 31, 2022, The Co. Ended The Year With An Unaudited Treasury Position Of $13.3M; Co. Is Now Prioritizing Discovery Endeavors To Tackle The Major Current Limitations Of CAR T-Cell Therap…

Celyad Oncology has implemented a strategic shift from an organization focused on clinical development to one fully harnessing the true potential of its proprietary technology platforms and intellectual property The

CYAD

Read More

Reported Late Thursday, Marathon Digital Holdings Announces 687 Bitcoin Produced In January, Up 45% MoM; Increased Unrestricted Cash To $133.8M And Increased Unrestricted Bitcoin Holdings To 8,090 BTC As Of January 31; Mining Operation Updates

Produced a Record 687 BTC in January 2023, 45% Increase from the Prior Month Increased Unrestricted Cash to $133.8 Million and Increased Unrestricted Bitcoin Holdings to 8,090 BTC as of January

MARA